19 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
ABT Abbott Laboratories $67.67 $118.71B N/A
Article Searches
Abbott Partners With Sanofi to Upgrade Diabetes Management http://www.zacks.com/stock/news/522662/abbott-partners-with-sanofi-to-upgrade-diabetes-management?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-522662 Sep 17, 2019 - Abbott (ABT) collaborates with Sanofi to revolutionize diabetes care through technological advancements.
Abbott Forms Alliance With Omada Health for Diabetes Care http://www.zacks.com/stock/news/565703/abbott-forms-alliance-with-omada-health-for-diabetes-care?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-565703 Oct 15, 2019 - Abbott (ABT) collaborates with Omada Health to revolutionize diabetes care by expanding technological access.
Story Stocks: Abbott Labs' diabetes care unit shines, but stock flutters on mediocre cardiovascular results (ABT) https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=NS20191016103542StoryStocks Oct 16, 2019 - In September of 2017, medical device company Abbott Labs (ABT) launched a new glucose monitoring sys
Abbott Laboratories (ABT) Q3 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/10/16/abbott-laboratories-abt-q3-2019-earnings-call-tran.aspx?source=iedfolrf0000001 Oct 16, 2019 - ABT earnings call for the period ending September 30, 2019.
Here's Why You Should Hold on to Abbott (ABT) Stock for Now http://www.zacks.com/stock/news/578612/heres-why-you-should-hold-on-to-abbott-abt-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-578612 Oct 23, 2019 - Investors continue to be optimistic about Abbott's (ABT) performance.
Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More http://www.zacks.com/stock/news/593569/medical-instruments-oct-31-earnings-roster-idxx-abmd-more?cid=CS-ZC-FT-analyst_blog:_earnings_preview_-_esp|earnings_preview_-_esp-593569 Oct 30, 2019 - Earnings and revenues for the Medical Instruments sector in the third quarter are likely to have declined sequentially. Read to know how a few companies from the sector might have fared in the period.
Medical Products' Nov 7 Earnings Roster: ABC, CAH & More http://www.zacks.com/stock/news/606407/medical-products-nov-7-earnings-roster-abc-cah-more?cid=CS-ZC-FT-analyst_blog:_earnings_preview_-_esp|earnings_preview_-_esp-606407 Nov 06, 2019 - Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.
Here's Why You Should Hold on to Thermo Fisher (TMO) for Now http://www.zacks.com/stock/news/499537/heres-why-you-should-hold-on-to-thermo-fisher-tmo-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-499537 Sep 03, 2019 - Investors continue to be optimistic about Thermo Fisher's (TMO) performance.
Abbott Receives European Nod for Pediatric Heart Devices http://www.zacks.com/stock/news/524246/abbott-receives-european-nod-for-pediatric-heart-devices?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-524246 Sep 18, 2019 - Abbott (ABT) aims to offer better treatment options for the most vulnerable patient population.
CGM Devices Gain Steam, Set New Trend in Diabetes Management http://www.zacks.com/stock/news/527773/cgm-devices-gain-steam-set-new-trend-in-diabetes-management?cid=CS-ZC-FT-analyst_blog|industry_focus-527773 Sep 20, 2019 - The FDA authorization classifies the new type of CGM devices in class II and subjects these to certain criteria called special controls.

Pages: 12

Page 1